Zepbound, a medication containing tirzepatide, has shown remarkable results in helping people lose significant amounts of weight, with some clinical trials reporting weight loss of around 20% or more over several months of treatment1 . However, stopping Zepbound often leads to weight regain, which poses challenges for long-term obesity management1 . Understanding the extent and mechanisms of weight regain after discontinuation is essential for patients and healthcare providers considering this treatment2 .
Mounjaro and Zepbound are not recommended for short-term use. Stopping these medications can lead to weight regain, increased appetite, and blood sugar spikes, underscoring the importance of long-term management and medical supervision11 .
Weight Regain After Zepbound Discontinuation
Tirzepatide, marketed as Zepbound, is a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist approved by the FDA for chronic weight management in adults with obesity or overweight with related health conditions3 4. Clinical trials, including the SURMOUNT-4 study, have demonstrated that adults treated with tirzepatide can achieve an average body weight reduction of approximately 20.9% after 36 weeks of treatment5 62.
However, when treatment is stopped, many patients experience substantial weight regain. In the SURMOUNT-4 trial, participants who discontinued tirzepatide and switched to placebo regained about 14% of the weight they had lost within one year5 62. Conversely, those who continued tirzepatide treatment experienced an additional 5.5% weight loss during the same period5 62. Overall, after 88 weeks, patients who stopped the drug still maintained a net weight loss of about 9.9%, indicating they regained roughly half of their initial weight loss7 .
This pattern of weight regain is consistent with observations from other GLP-1 receptor agonists used for obesity treatment. Biological compensatory mechanisms, including hormonal changes and loss of central nervous system regulation of appetite, contribute to the rebound weight gain after stopping these medications8 910. The drugs reduce appetite and cravings by acting on brain pathways and digestive hormones, but these effects diminish once the medication is discontinued, leading to increased hunger and food intake11 .
If you look at the magnitude of the weight gain, they gain back about half the weight they had originally lost over a one-year period of time.
— Louis J. Aronne, Weill Cornell Medicine7
Weight regain after stopping Zepbound can begin quickly, often within one to two weeks, as appetite returns to pre-treatment levels11 . Some patients may also notice changes in food taste or cravings due to the drug’s influence on brain reward pathways, although evidence for taste changes is limited11 . Additionally, mood changes such as anxiety or depression may occur during or after treatment cessation, possibly related to fluctuations in appetite and weight11 .
Because obesity is a chronic metabolic condition, ongoing treatment is often necessary to maintain weight loss and associated health benefits2 . Discontinuing Zepbound may also reverse improvements in related conditions such as obstructive sleep apnea, which is closely linked to body weight12 .
Table 1. Weight Outcomes After 36 Weeks and Following 52 Weeks of Continued or Discontinued Tirzepatide Treatment
| Parameter | Value/Description | Source(s) |
|---|---|---|
| Average weight loss at 36 weeks | ~20.9% body weight reduction | 56 |
| Additional weight loss with continued treatment (52 weeks) | 5.5% body weight | 56 |
| Weight regain after stopping (placebo group, 52 weeks) | 14% body weight regained | 56 |
| Net weight loss after 88 weeks (stopped group) | 9.9% body weight reduction maintained | 7 |
Tips to Minimize Weight Regain After Stopping Zepbound
- Monitor daily calorie intake carefully to avoid excess consumption13 .
- Maintain a balanced diet rich in protein, fruits, and vegetables13 .
- Eat smaller, frequent meals instead of skipping meals or having large portions13 .
- Engage in regular physical activity, including strength training, to preserve muscle mass13 .
- Get adequate sleep to help regulate hunger and cravings13 .
Stopping Zepbound often causes weight gain. The majority of people regain significant weight when they go off the drug. This rebound is due to the body’s natural mechanisms to restore lost weight once the medication’s appetite-suppressing effects wear off1 .
Determining If Zepbound Is Right for You
Zepbound is FDA-approved for adults with a body mass index (BMI) of 30 or higher, or those with a BMI of 27 or higher who also have at least one weight-related comorbidity such as hypertension, obstructive sleep apnea, or dyslipidemia3 1415. These criteria help identify individuals who may benefit most from treatment.
Tirzepatide works by mimicking the actions of GLP-1 and GIP hormones, which regulate insulin secretion, appetite, and digestion. This dual mechanism may provide greater weight loss effects than GLP-1 receptor agonists alone16 . Clinical trials suggest that Zepbound can help patients lose between 15% and 22% of their body weight when combined with diet and lifestyle changes17 16.
Common side effects of Zepbound include gastrointestinal symptoms such as nausea, diarrhea, and injection site irritation5 18. There is a theoretical but unconfirmed risk of thyroid C-cell tumors based on animal studies, though long-term safety data in humans remain limited3 1810. Clinical experience with GLP-1 receptor agonists, including tirzepatide, indicates good tolerability over several years, but more research is needed on intermittent use and long-term effects beyond a few years10 3.
Weight loss medication or surgery is part of an entire treatment package that includes a nutritional plan that emphasizes unprocessed foods. You need to eat lots of fresh fruits, vegetables, and whole grains, and get adequate sleep.
— Richard Siegel, Tufts University School of Medicine16
Insurance coverage and cost often influence the choice and duration of treatment with Zepbound and other GLP-1 receptor agonists5 10. Because obesity is a chronic disease, many experts recommend specialist consultation to optimize treatment plans, including medication use, lifestyle interventions, and monitoring5 15.
Key Considerations Before Starting Zepbound
- Confirm eligibility based on BMI and presence of comorbidities3 15.
- Understand that Zepbound is intended for long-term use to maintain weight loss11 .
- Be aware of potential gastrointestinal side effects and discuss management strategies with your healthcare provider5 18.
- Consider insurance coverage and out-of-pocket costs5 10.
- Plan for regular follow-up to monitor weight, side effects, and related health conditions5 15.
